DTC Print Ads: Package Insert Info Is Out, Drug Facts Box Is In
This article was originally published in The Pink Sheet Daily
FDA’s revised draft guidance for disclosing risk information in direct-to-consumer print ads advises against the use of package insert information in the brief summary; suggests Drugs Facts box or Q&A as alternative formats.
You may also be interested in...
First Amendment litigation and guidance document work may be factors behind decline.
Article suggests that a Drug Facts box could specify the proportion of patients who benefitted from the drug in key trials and how many had adverse events; PhRMA calls for revision to regulations, preclearance regime.